Royal Bank of Canada lifted its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 14.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 5,831,624 shares of the medical research company’s stock after acquiring an additional 751,947 shares during the period. […]
Comerica Bank lowered its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 244,981 shares of the medical research company’s stock after selling 8,247 shares during the quarter. Comerica Bank’s holdings in Amgen […]
Comerica Bank trimmed its stake in shares of Amgen Inc. (NASDAQ:AMGN – Free Report) by 3.3% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 244,981 shares of the medical research company’s stock after selling 8,247 shares during the period. Comerica Bank’s holdings in Amgen […]
Pin Oak Investment Advisors Inc. lessened its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 25.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 291 shares of the medical research company’s stock after selling 100 shares during the quarter. Pin Oak […]
True Wealth Design LLC lowered its position in Amgen Inc. (NASDAQ:AMGN – Free Report) by 6.2% during the fourth quarter, according to its most recent filing with the SEC. The firm owned 3,079 shares of the medical research company’s stock after selling 203 shares during the period. True Wealth Design LLC’s holdings in Amgen were […]